Gerostate Alpha
Novato
About Gerostate Alpha
Gerostate Alpha is tackling human aging, an ambitious goal. The three co-founders are all academics at the Buck Institute where they’ve spent years researching aging. They’ve used their proprietary platform for drug discovery to quickly parse 90,000 compounds and identify 150 hits for further research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $714.6K
- Last round: Equity Crowdfunding (Sep 2021)
- Website: gerostatealpha.com
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/gerostate-alpha-48946 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.